Over the last 22 years, Gregory Stewart, Ph.D., has helped to translate a variety of pharmaceutical and biotechnology projects from the laboratory to the clinic while working at Medtronic Neuromodulation, Genzyme, ALZA Roche Bioscience and Syntex Discovery Research. Therapeutic projects ranged from small molecules and protein neurotrophic factors to cell transplantation and viral vector-based gene transfer for a variety of neurologic disorders including chronic pain, spasticity, neurometabolic syndromes, and neurodegenerative disease. Most recently, Dr. Stewart served as the Director of Central Nervous System Drug Therapy at Medtronic Neuromodulation focusing on the development of drug:device combination products for delivery of drugs directly to the brain and spinal cord. At present, Dr. Stewart has started his own consulting practice, Alchemy Neuroscience, aimed at providing tactical and strategic support for companies whose products have reached the often difficult bench to bedside stage of development.
Dr. Stewart received his B.S. in Neuroscience from Texas Christian University in 1983, and Ph.D. in Neural Sciences from Washington University in St. Louis in 1989. Before moving to industry, he was a Staff Fellow studying developmental neurobiology at the National Institute of Mental Health. When not working, Dr. Stewart enjoys hiking, traveling, and photography. He also loves ancient history, especially the period of the Roman Republic and Empire. Dr. Stewart lives with his wife and son in Plymouth, Minnesota.